These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26367473)

  • 1. Extended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats.
    D'Arcy C; Luevano JE; Miranda-Arango M; Pipkin JA; Jackson JA; Castañeda E; Gosselink KL; O'Dell LE
    Behav Brain Res; 2016 Jan; 296():125-128. PubMed ID: 26367473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.
    Laćan G; Hadamitzky M; Kuczenski R; Melega WP
    Synapse; 2013 Aug; 67(8):476-88. PubMed ID: 23417852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
    Shepard JD; Chuang DT; Shaham Y; Morales M
    Psychopharmacology (Berl); 2006 May; 185(4):505-13. PubMed ID: 16555063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
    Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
    PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.
    Schwendt M; Rocha A; See RE; Pacchioni AM; McGinty JF; Kalivas PW
    J Pharmacol Exp Ther; 2009 Nov; 331(2):555-62. PubMed ID: 19648469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.
    Tunstall BJ; Ho CP; Cao J; Vendruscolo JCM; Schmeichel BE; Slack RD; Tanda G; Gadiano AJ; Rais R; Slusher BS; Koob GF; Newman AH; Vendruscolo LF
    Neuropharmacology; 2018 Mar; 131():96-103. PubMed ID: 29217282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
    Chauhan H; Killinger BA; Miller CV; Moszczynska A
    Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
    Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
    BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
    Cervinski MA; Foster JD; Vaughan RA
    J Biol Chem; 2005 Dec; 280(49):40442-9. PubMed ID: 16204245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP.
    Albers DS; Zeevalk GD; Sonsalla PK
    Brain Res; 1996 Apr; 718(1-2):217-20. PubMed ID: 8773791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurochemical consequences of methamphetamine self-administration in male and female rats.
    Johansen A; McFadden LM
    Drug Alcohol Depend; 2017 Sep; 178():70-74. PubMed ID: 28645061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.